| Literature DB >> 33801234 |
Sarah E Fenton1,2, Diana Saleiro1,2, Leonidas C Platanias1,2,3.
Abstract
The interferons (IFNs) are essential components of the immune response against infections and malignancies. IFNs are potent promoters of the anti-tumor response, but there is also evidence that feedback mechanisms regulated by IFNs negatively control immune responses to avoid hyper-activation and limit inflammation. This balance of responses plays an important role in cancer surveillance, immunoediting and response to anticancer therapeutic approaches. Here we review the roles of both type I and type II IFNs on the control of the immune response against malignancies in the context of effects on both malignant cells and cells of the immune system in the tumor microenvironment.Entities:
Keywords: T cell; cancer; cancer immunoediting; dendritic cell; interferons; macrophage
Year: 2021 PMID: 33801234 PMCID: PMC7957896 DOI: 10.3390/cancers13051037
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639